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Background: Patients with Marfan Syndrome (MS) or bicuspid aortic valves (BAV) are at increased risk for aortic dissection. Surgical guidelines 
primarily use the diameter of the ascending aortic (dAA) to assess dissection risk in these patients. We used the International Registry of Acute Aortic 
Dissection (IRAD) database to retrospectively examine dAA in MS and BAV dissection patients and gauge the effectiveness of size-based guidelines 
in preventing dissections. We also compared outcomes after treatment in these patients.
Methods: We used the IRAD database to stratify Type A acute aortic dissection patients from 1996 to 2011 into groups with MS (n=51), BAV 
(n=64) or neither of these conditions (n=1514). dAA was used to determine the percent of patients with MS or BAV who dissected at various sizes. 
Outcomes were compared in the three groups based on aortic size.
Results: The dAA was <5cm and <4.5cm in a large proportion of patients (see graph). There were no significant differences in long-term outcomes 
amongst MS or BAV patients when stratified by dAA at time of dissection.
Conclusion: Analysis of the IRAD database showed a significant proportion of MS and BAV patients dissecting at dAA <5cm. In addition, dAA 
at time of dissection was not correlated with differences in outcomes. Rather than primarily using size, future development of a personalized risk 
assessment approach that combines genetics, proteomics and dynamic imaging will allow for better identification of those at risk for dissections.
 
